These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7716400)

  • 1. Knowledge and attitudes toward onchocerciasis in the Thyolo highlands of Malawi.
    Johnston K; Courtright P; Burnham G
    Trop Med Parasitol; 1994 Dec; 45(4):341-3. PubMed ID: 7716400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin distribution and the cultural context of forest onchocerciasis in South Province, Cameroon.
    Hewlett BS; Kollo B; Cline BL
    Am J Trop Med Hyg; 1996 May; 54(5):517-22. PubMed ID: 8644908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
    Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
    Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitudes and perceptions (KAP) of onchocerciasis: a survey among residents in an endemic area in Guatemala targeted for mass chemotherapy with ivermectin.
    Richards F; Klein RE; Gonzales-Peralta C; Flores RZ; Flores GZ; Ramírez JC
    Soc Sci Med; 1991; 32(11):1275-81. PubMed ID: 2068610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onchocerciasis control in Uganda.
    Ndyomugyenyi R
    World Health Forum; 1998; 19(2):192-5. PubMed ID: 9652221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endemicity of onchocerciasis in some local government areas of Niger state.
    Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
    Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
    Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
    Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new cytoforms of the Simulium damnosum complex (Diptera: Simuliidae) from Malawi and Tanzania and potential onchocerciasis vectors.
    Krüger A; Kalinga AK; Post RJ; Maegga BT
    Trop Med Int Health; 2004 Jul; 9(7):805-11. PubMed ID: 15228490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species complex of vectors and epidemiology.
    Vajime CG; Gregory WG
    Acta Leiden; 1990; 59(1-2):235-52. PubMed ID: 2198755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onchocerciasis in the Democratic Republic of Congo: Survey of knowledge, attitude and perception in Bandundu province.
    Makenga Bof JC; Mpunga D; Soa EN; Ntumba F; Bakajika D; Murdoch ME; Coppieters Y
    J Infect Public Health; 2017; 10(5):600-607. PubMed ID: 28215917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of ivermectin in the control of onchocerciasis].
    Chippaux JP; Boussinesq M; Prod'hon J
    Sante; 1995; 5(3):149-58. PubMed ID: 7640897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectors of onchocerciasis in the Thyolo Highlands and other onchocerciasis foci in Malawi.
    Roberts MJ
    Acta Leiden; 1990; 59(1-2):45-7. PubMed ID: 2378225
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.
    Emukah EC; Osuoha E; Miri ES; Onyenama J; Amazigo U; Obijuru C; Osuji N; Ekeanyanwu J; Amadiegwu S; Korve K; Richards FO
    Am J Trop Med Hyg; 2004 May; 70(5):556-61. PubMed ID: 15155991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onchocerciasis in Malawi. 2. Subjective complaints and decreased weight in persons infected with Onchocerca volvulus in the Thyolo highlands.
    Burnham GM
    Trans R Soc Trop Med Hyg; 1991; 85(4):497-500. PubMed ID: 1836686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
    Oyibo WA; Fagenro-Beyioku AF
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):496-503. PubMed ID: 12693582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
    Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
    East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
    Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.